Tempus AI maintains buy rating as Canaccord adjusts price target to $95 after Q3
Tempus AI, Inc. (NASDAQ:TEM) is one of the The best digital health stocks to buy now. Wall Street sentiment toward Tempus AI strengthened on Nov. 5, 2025, following the company’s third-quarter results, with three major companies reiterating positive ratings and updating their targets. Canaccord Genuity maintained its Buy rating, but slightly cut its target from…